Literature DB >> 35445250

Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.

Fatema Tuz Zahra1, Gabrielle Grubbs1, Kirsten Dummer2, Adriana H Tremoulet2, Chisato Shimizu2, Jane C Burns2, Surender Khurana1.   

Abstract

Our study demonstrates that children who developed SARS-CoV-2 vaccination-induced myocarditis and may not receive another vaccination, could be susceptible to infection with Omicron and emerging variants. We observed higher neutralizing antibody titers in myocarditis patients vs. healthy vaccinated children, but significantly lower neutralization titers against Omicron in both groups. © Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2022.

Entities:  

Keywords:  COVID-19; Myocarditis; Omicron; SARS-CoV-2; Vaccination

Year:  2022        PMID: 35445250      PMCID: PMC9047211          DOI: 10.1093/cid/ciac323

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  1 in total

1.  Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Young Adults With Inflammatory Bowel Disease Receiving Biologics.

Authors:  Lorenza Bellusci; Fatema Tuz Zahra; Dena E Hopkins; Juan C Salazar; Jeffrey S Hyams; Surender Khurana
Journal:  Gastroenterology       Date:  2022-08-10       Impact factor: 33.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.